-
1دورية أكاديمية
المؤلفون: Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls
المصدر: Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2044-5385
-
2دورية أكاديمية
المؤلفون: Jeroen Janssen, Bob Löwenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, Anna Efthymiou, Bjørn-Tore Gjertsen, Carlos Graux, Michael Gregor, Dominik Heim, Urs Hess, Mels Hoogendoorn, Aurelie Jaspers, Asiong Jie, Mojca Jongen-Lavrencic, Saskia Klein, Marjolein van der Klift, Jürgen Kuball, Danielle van Lammeren-Venema, Marie-Cecile Legdeur, Arjan van de Loosdrecht, Johan Maertens, Marinus van Marwijk Kooy, Ine Moors, Marten Nijziel, Florence van Obbergh, Margriet Oosterveld, Thomas Pabst, Marjolein van der Poel, Harm Sinnige, Olivier Spertini, Wim Terpstra, Lidwine Tick, Walter van der Velden, Marie-Christiane Vekemans, Edo Vellenga, Okke de Weerdt, Peter Westerweel, Georg Stüssi, Yvette van Norden, Gert Ossenkoppele
المصدر: Cancers, Vol 13, Iss 4, p 672 (2021)
مصطلحات موضوعية: AML, high-risk MDS, tosedostat, clinical trial, aminopeptidase inhibitor, elderly, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Markus G. Manz, Harm Sinnige, Marie-Christiane Vekemans, Jürgen Kuball, Yves Chalandon, Dominik Heim, Lidwine W. Tick, Thomas Pabst, Peter E. Westerweel, Marjolein van der Poel, Dimitri Breems, Jeroen Janssen, Marie-Cecile Legdeur, Ine Moors, Carlos Graux, Rolf E. Brouwer, Wim Terpstra, Danielle van Lammeren-Venema, Dries Deeren, Johan Maertens, Okke de Weerdt, Peter A. von dem Borne, Marinus van Marwijk Kooy, Marten R. Nijziel, Arjan A. van de Loosdrecht, Mojca Jongen-Lavrencic, Mels Hoogendoorn, Florence Van Obbergh, Yvette van Norden, Anna Efthymiou, Bjørn-Tore Gjertsen, Georg Stussi, Gert J. Ossenkoppele, Margriet Oosterveld, Bart J. Biemond, Asiong Jie, Mario Bargetzi, Edo Vellenga, Marjolein van der Klift, Aurélie Jaspers, Saskia K. Klein, Olivier Spertini, Walter J.F.M. van der Velden, Urs Hess, Bob Löwenberg, Michael Gregor
المساهمون: UCL - (SLuc) Service d'hématologie, UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'hématologie, Internal medicine, VU University medical center, Hematology laboratory, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Graduate School, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Hematology, Orthopedics and Sports Medicine
المصدر: Cancers, vol. 13, no. 4, pp. 672
Cancers, Vol. 13, No 4 (2021) P. 672
Cancers
Volume 13
Issue 4
Cancers, 13
Janssen, J, Löwenberg, B, Manz, M, Bargetzi, M, Biemond, B, von dem Borne, P, Breems, D, Brouwer, R, Chalandon, Y, Deeren, D, Efthymiou, A, Gjertsen, B T, Graux, C, Gregor, M, Heim, D, Hess, U, Hoogendoorn, M, Jaspers, A, Jie, A, Jongen-Lavrencic, M, Klein, S, van der Klift, M, Kuball, J, van Lammeren-Venema, D, Legdeur, M C, van de Loosdrecht, A, Maertens, J, Kooy, M V M, Moors, I, Nijziel, M, van Obbergh, F, Oosterveld, M, Pabst, T, van der Poel, M, Sinnige, H, Spertini, O, Terpstra, W, Tick, L, van der Velden, W, Vekemans, M C, Vellenga, E, de Weerdt, O, Westerweel, P, Stüssi, G, van Norden, Y & Ossenkoppele, G 2021, ' Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds ', Cancers, vol. 13, no. 4, 672, pp. 1-11 . https://doi.org/10.3390/cancers13040672
Cancers, Vol. 13, no. 4, p. 672 [1-11] (2021)
Cancers, Vol 13, Iss 672, p 672 (2021)
Cancers, 13(4):672, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672 <http://dx.doi.org/10.3390/cancers13040672>
Cancers, 13, 4
Cancers, 13(4):672. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(4):672. MDPI AG
CANCERSمصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_treatment, Phases of clinical research, AML, aminopeptidase inhibitor, clinical trial, elderly, high-risk MDS, tosedostat, Aminopeptidase inhibitor, 0302 clinical medicine, Elderly, Tosedostat, Medicine and Health Sciences, ddc:616, education.field_of_study, aminopeptidase, Intensive treatment, Atrial fibrillation, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, inhibitor, Clinical trial, Oncology, 030220 oncology & carcinogenesis, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Population, 610 Medicine & health, lcsh:RC254-282, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, medicine, education, Chemotherapy, Science & Technology, business.industry, medicine.disease, 030104 developmental biology, High-risk MDS, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Cytarabine, 610 Medizin und Gesundheit, business
وصف الملف: application/pdf; Electronic
-
4
المؤلفون: Marie-Christiane Vekemans, Wim H. van der Putten, Johan Maertens, Florentien E. M. in ’t Hout, Raynier Devillier, Bart J. Biemond, Jurjen Versluis, Thomas Pabst, Gert J. Ossenkoppele, Jan J. Cornelissen, Peter J. M. Valk, Roel Willemze, Bob Löwenberg, Markus G. Manz, Frédéric Baron, Giovanna Meloni, Bert A. van der Reijden, Harry C. Schouten, Gerwin Huls, Marie-Cecile Legdeur, Edo Vellenga, Jakob Passweg, Jürgen Kuball
المساهمون: CCA - Cancer Treatment and Quality of Life, Clinical Haematology, CCA -Cancer Center Amsterdam, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL), UCL - (SLuc) Service d'hématologie, Hematology, CCA - Cancer Treatment and quality of life, University of Zurich, Cornelissen, J J, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde
المصدر: Leukemia, 31(1), 26-33. Nature Publishing Group
Leukemia, 31, 26-33. Nature Publishing Group
Leukemia, Vol. 31, no.1, p. 26-33 (2016)
Leukemia, 31, 1, pp. 26-33
Leukemia, 31, 26. Nature Publishing Group
Leukemia, 31, 26-33
Versluis, J, In'T Hout, F E M, Devillier, R, Van Putten, W L J, Manz, M G, Vekemans, M C, Legdeur, M C, Passweg, J R, Maertens, J, Kuball, J, Biemond, B J, Valk, P J M, Van Der Reijden, B A, Meloni, G, Schouten, H C, Vellenga, E, Pabst, T, Willemze, R, Löwenberg, B, Ossenkoppele, G, Baron, F, Huls, G & Cornelissen, J J 2017, ' Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio ', Leukemia, vol. 31, no. 1, pp. 26-33 . https://doi.org/10.1038/leu.2016.183مصطلحات موضوعية: Oncology, Male, Cancer Research, Transplantation Conditioning, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], 2720 Hematology, Hematopoietic stem cell transplantation, UK MRC AML-10, Allelic ratio, 0302 clinical medicine, hemic and lymphatic diseases, 1306 Cancer Research, Cumulative incidence, ALLOGENEIC TRANSPLANTATION, Precision Medicine, 610 Medicine & health, ACUTE MYELOGENOUS LEUKEMIA, NO-DONOR ANALYSIS, Hazard ratio, Remission Induction, Hematopoietic Stem Cell Transplantation, Nuclear Proteins, Hematology, 1ST COMPLETE REMISSION, Middle Aged, Survival Rate, Leukemia, Leukemia, Myeloid, Acute, Tandem Repeat Sequences, 030220 oncology & carcinogenesis, 2730 Oncology, Female, Nucleophosmin, REDUCED-INTENSITY, Flt3 itd, Adult, NPM1, medicine.medical_specialty, Adolescent, MINIMAL RESIDUAL DISEASE, ACUTE MYELOID-LEUKEMIA, Risk Assessment, 03 medical and health sciences, Young Adult, Internal medicine, Journal Article, medicine, Humans, Comparative Study, Survival rate, business.industry, STEM-CELL TRANSPLANTATION, medicine.disease, Minimal residual disease, INTERNAL TANDEM DUPLICATION, Anesthesiology and Pain Medicine, fms-Like Tyrosine Kinase 3, 10032 Clinic for Oncology and Hematology, Immunology, Fms-Like Tyrosine Kinase 3, Mutation, business, Value (mathematics), 030215 immunology
وصف الملف: image/pdf; application/pdf; 132928.pdf - application/pdf
-
5
المؤلفون: Carlos Graux, Mojca Jongen-Lavrencic, Thomas Pabst, Harry C. Schouten, Jurjen Versluis, Jakob Passweg, Jeroen Janssen, Vincent H.J. van der Velden, Marie-Christiane Vekemans, Mels Hoogendoorn, Wendelien Zeijlemaker, Burak Kalin, Okke de Weerdt, Marie-Cecile Legdeur, Pierre W. Wijermans, Marinus van Marwijk Kooy, Bart J. Biemond, Markus G. Manz, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, J. Kuball, Mario Bargetzi, Bob Löwenberg, Jan J. Cornelissen
المساهمون: Internal Medicine, Hematology, Immunology, UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie
المصدر: JCO Precision Oncology, 2017(1), 1-13. American Society of Clinical Oncology
JCO precision oncology, Vol. 1, no.1, p. 1-13 (2017)مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, 03 medical and health sciences, 0302 clinical medicine, Immunophenotyping, SDG 3 - Good Health and Well-being, hemic and lymphatic diseases, Internal medicine, medicine, 610 Medicine & health, Chemotherapy, business.industry, Induction chemotherapy, Myeloid leukemia, Minimal residual disease, Surgery, body regions, Transplantation, Haematopoiesis, 030220 oncology & carcinogenesis, Stem cell, business, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7444c9d61ef0d160e17eff92e6cef147
https://doi.org/10.1200/PO.17.00078 -
6
المؤلفون: K.S. van der Lee, H. Wilmink, Remy Klaassen, Marie-Cecile Legdeur, Dick J. Richel, H.W.M. van Laarhoven, Aart J. Nederveen, Esther N. Pijnappel, M. Pleunis van Empel
المصدر: Annals of Oncology. 30:v265
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Neutropenia, Sonidegib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Pancreatic cancer, Medicine, health care economics and organizations, Performance status, business.industry, Hematology, medicine.disease, Chemotherapy regimen, Gemcitabine, Clinical trial, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, business, Progressive disease, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9b2c341318fe606154c49a4d859a24c6
https://doi.org/10.1093/annonc/mdz247.022 -
7
المؤلفون: Thomas, Pabst, Edo, Vellenga, Wim, van Putten, Harry C, Schouten, Carlos, Graux, Marie-Christiane, Vekemans, Bart, Biemond, Peter, Sonneveld, Jakob, Passweg, Leo, Verdonck, Marie-Cecile, Legdeur, Matthias, Theobald, Emanuel, Jacky, Mario, Bargetzi, Johan, Maertens, Gert Jan, Ossenkoppele, Bob, Löwenberg, M, Van Marwijk Kooy
المساهمون: Cardiology, Hematology, Faculteit Medische Wetenschappen/UMCG, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL), CCA - Innovative therapy, Interne Geneeskunde, RS: GROW - School for Oncology and Reproduction
المصدر: Blood, 119(23), 5367-5373. American Society of Hematology
Blood, 119(23), 5367-5373. AMER SOC HEMATOLOGY
Pabst, T, Vellenga, E, van Putten, W, Schouten, H C, Graux, C, Vekemans, M C, Biemond, B, Sonneveld, P, Passweg, J, Verdonck, L, Legdeur, M C, Theobald, M, Jacky, E, Bargetzi, M, Maertens, J, Ossenkoppele, G J & Lowenberg, B 2012, ' Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine ', Blood, vol. 119, no. 23, pp. 5367-5373 . https://doi.org/10.1182/blood-2011-11-389841
Blood, 119(23), 5367-5373. The American Society of Hematologyمصطلحات موضوعية: Adult, Male, Oncology, Antimetabolites, Antineoplastic, medicine.medical_specialty, medicine.medical_treatment, Immunology, Biochemistry, Disease-Free Survival, POOR-PROGNOSIS, ARA-C, Internal medicine, Granulocyte Colony-Stimulating Factor, FACTOR GM-CSF, ELDERLY PATIENTS, medicine, Humans, GROWTH-FACTORS, ADVANCED MYELODYSPLASTIC SYNDROME, Chemotherapy, ACUTE MYELOGENOUS LEUKEMIA, business.industry, Remission Induction, Cytarabine, Induction chemotherapy, Myeloid leukemia, Induction Chemotherapy, Cell Biology, Hematology, Middle Aged, Prognosis, medicine.disease, INTENSIVE CHEMOTHERAPY, Chemotherapy regimen, COOPERATIVE GROUP, Granulocyte colony-stimulating factor, Surgery, Leukemia, Myeloid, Acute, Regimen, Leukemia, Treatment Outcome, CYTOSINE-ARABINOSIDE, Female, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536bfa064c36524bd95b78caac4290b3
https://doi.org/10.1182/blood-2011-11-389841 -
8
المؤلفون: Maarten J. Deenen, Henk Boot, Annemieke Cats, Marie-Cecile Legdeur, Didier Meulendijks, Jan H.M. Schellens, Jos H. Beijnen
المصدر: Cancer Chemotherapy and Pharmacology, 76(6), 1285. Springer Verlag
مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Cancer Research, Esophageal Neoplasms, Organoplatinum Compounds, Nausea, Metabolic Clearance Rate, Docetaxel, Neutropenia, Toxicology, Polymorphism, Single Nucleotide, Disease-Free Survival, Capecitabine, Leukocytopenia, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacokinetics, Pharmacology (medical), Genetic Predisposition to Disease, Fatigue, Aged, Pharmacology, business.industry, Alopecia, Middle Aged, medicine.disease, Oxaliplatin, Regimen, Treatment Outcome, Pharmacogenetics, Area Under Curve, Female, Taxoids, Esophagogastric Junction, medicine.symptom, business, Gastric cancer, Febrile neutropenia, medicine.drug
وصف الملف: application/pdf
-
9
المؤلفون: Geke A. P. Hospers, Bruno van der Holt, Rudi M. H. Roumen, Henk M.W. Verheul, Rob L. H. Jansen, Pieter J. Tanis, Sandra A Radema, Ninos Ayez, Nelly van der Meer, Ferry A.L.M. Eskens, Hans de Wilt, Dirk J. Grünhagen, Cornelis J. A. Punt, Marie-Cecile Legdeur, Richard van Hillegersberg, Eric P. van der Stok, Joost M. Klaase, Cornelis H. C. Dejong, Gerard Vreugdenhil, Esther van Meerten, Koert P. de Jong, Cornelis Verhoef
المساهمون: Medical oncology, CCA - Innovative therapy, Surgery, RS: NUTRIM - R2 - Gut-liver homeostasis, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Medical Oncology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Oncology, Groningen Institute for Organ Transplantation (GIOT), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Value, Affordability and Sustainability (VALUE)
المصدر: BMC Cancer, 15:180. BioMed Central
BMC Cancer, 15
BMC Cancer
BMC Cancer, 15:180. BioMed Central Ltd
BMC Cancer, 15. BioMed Central Ltd.
BMC cancer, 15(1). BioMed Central
BMC Cancer, 15:180. BMC
Ayez, N, van der Stok, E P, de Wilt, H, Radema, S A, van Hillegersberg, R, Roumen, R M, Vreugdenhil, G, Tanis, P J, Punt, C J, Dejong, C H, Jansen, R L, Verheul, H M, de Jong, K P, Hospers, G A, Klaase, J M, Legdeur, M C, van Meerten, E, Eskens, F A, van der Meer, N, van der Holt, B, Verhoef, C & Grunhagen, D J 2015, ' Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial ', BMC Cancer, vol. 15, 180 . https://doi.org/10.1186/s12885-015-1199-8مصطلحات موضوعية: Male, Cancer Research, Organoplatinum Compounds, medicine.medical_treatment, PROGNOSTIC SCORING SYSTEM, THERAPY, law.invention, Study Protocol, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], ADJUVANT CHEMOTHERAPY, PROPOSAL, Randomized controlled trial, Surgical oncology, law, Risk Factors, Medicine, Neoadjuvant therapy, Digestive System Surgical Procedures, Liver Neoplasms, Middle Aged, CANCER, Combined Modality Therapy, Neoadjuvant Therapy, Oxaliplatin, Oncology, Surgical resection, Clinical risk score, SURVIVAL, Female, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, HEPATIC RESECTION, Disease-Free Survival, Genetics, Humans, Aged, Chemotherapy, business.industry, PERIOPERATIVE CHEMOTHERAPY, Cancer, Neo-adjuvant chemotherapy, medicine.disease, PHASE-III, Surgery, Clinical trial, Colorectal liver metastases, FOLFOX4, business
وصف الملف: application/pdf
-
10
المؤلفون: G. Paardekooper, Dankert Woutersen, A. Slot, J.Th.M. Plukker, W. E. Fiets, Christina T. Muijs, Geke A. P. Hospers, Marie-Cecile Legdeur, Jannet C. Beukema, Justin K. Smit, Johannes G. M. Burgerhof, J.W.B. de Groot, Karin Muller, Judith Honing
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Life Course Epidemiology (LCE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON)
المصدر: Annals of Oncology, 25(3), 638-643. Oxford University Press
مصطلحات موضوعية: Oncology, Male, endocrine system diseases, Esophageal Neoplasms, medicine.medical_treatment, NETHERLANDS, Gastroenterology, Carboplatin, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, chemoradiation, Hematology, Chemoradiotherapy, CHEMOTHERAPY, Middle Aged, Chemotherapy regimen, female genital diseases and pregnancy complications, Tubulin Modulators, Treatment Outcome, Paclitaxel, Fluorouracil, Chemotherapy, Adjuvant, SURVIVAL, Female, therapeutics, medicine.drug, medicine.medical_specialty, Antimetabolites, Antineoplastic, CARCINOMA, Antineoplastic Agents, Disease-Free Survival, esophageal, Internal medicine, medicine, cancer, Humans, neoplasms, Retrospective Studies, Cisplatin, Chemotherapy, business.industry, organic chemicals, definitive, Original Articles, Regimen, chemistry, Radiotherapy, Adjuvant, business, FOLLOW-UP
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acd71ba31f939ef95d896c8e295f4c2b
https://pubmed.ncbi.nlm.nih.gov/24492674
Find this article in full text from Springer Verlag. 
Full Text Finder